These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 1685016

  • 1. A 25 kDa polypeptide is the ligand for p185neu and is secreted by activated macrophages.
    Tarakhovsky A, Zaichuk T, Prassolov V, Butenko ZA.
    Oncogene; 1991 Dec; 6(12):2187-96. PubMed ID: 1685016
    [Abstract] [Full Text] [Related]

  • 2. Down-regulation of Fc receptor expression in guinea pig peritoneal exudate macrophages by muramyl dipeptide or lipopolysaccharide.
    Yagawa K, Kaku M, Ichinose Y, Nagao S, Tanaka A, Aida Y, Tomoda A.
    J Immunol; 1985 Jun; 134(6):3705-11. PubMed ID: 2985692
    [Abstract] [Full Text] [Related]

  • 3. The role of the neu oncogene product in cell transformation and normal development.
    Kokai Y, Wada T, Myers JN, Brown VI, Dobashi K, Cohen J, Hamuro J, Weiner DB, Greene MI.
    Princess Takamatsu Symp; 1988 Jun; 19():45-57. PubMed ID: 2908355
    [Abstract] [Full Text] [Related]

  • 4. Protective effect of neoglycoprotein-conjugated muramyl dipeptide against Leishmania donovani infection: the role of cytokines.
    Sarkar K, Das PK.
    J Immunol; 1997 Jun 01; 158(11):5357-65. PubMed ID: 9164956
    [Abstract] [Full Text] [Related]

  • 5. Oncogenic activation of the PDGF beta receptor by the transmembrane domain of p185neu*.
    Petti LM, Irusta PM, DiMaio D.
    Oncogene; 1998 Feb 19; 16(7):843-51. PubMed ID: 9484775
    [Abstract] [Full Text] [Related]

  • 6. Expression of the neu proto-oncogene by Schwann cells during peripheral nerve development and Wallerian degeneration.
    Cohen JA, Yachnis AT, Arai M, Davis JG, Scherer SS.
    J Neurosci Res; 1992 Apr 19; 31(4):622-34. PubMed ID: 1374476
    [Abstract] [Full Text] [Related]

  • 7. Constitutively activated neu oncoprotein tyrosine kinase interferes with growth factor-induced signals for gene activation.
    Lehtola L, Sistonen L, Koskinen P, Lehväslaiho H, Di Renzo MF, Comoglio PM, Alitalo K.
    J Cell Biochem; 1991 Jan 19; 45(1):69-81. PubMed ID: 1706346
    [Abstract] [Full Text] [Related]

  • 8. Linkage of tyrosine kinase activity with transforming ability of the p185neu oncoprotein.
    Weiner DB, Kokai Y, Wada T, Cohen JA, Williams WV, Greene MI.
    Oncogene; 1989 Oct 19; 4(10):1175-83. PubMed ID: 2571965
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of p185neu kinase activity and cellular transformation by co-expression of a truncated neu protein.
    Qian X, O'Rourke DM, Zhao H, Greene MI.
    Oncogene; 1996 Nov 21; 13(10):2149-57. PubMed ID: 8950982
    [Abstract] [Full Text] [Related]

  • 10. Expression pattern of the neu (NGL) gene-encoded growth factor receptor protein (p185neu) in normal and transformed epithelial tissues of the digestive tract.
    Cohen JA, Weiner DB, More KF, Kokai Y, Williams WV, Maguire HC, LiVolsi VA, Greene MI.
    Oncogene; 1989 Jan 21; 4(1):81-8. PubMed ID: 2563577
    [Abstract] [Full Text] [Related]

  • 11. Increased expression of specific protein tyrosine phosphatases in human breast epithelial cells neoplastically transformed by the neu oncogene.
    Zhai YF, Beittenmiller H, Wang B, Gould MN, Oakley C, Esselman WJ, Welsch CW.
    Cancer Res; 1993 May 15; 53(10 Suppl):2272-8. PubMed ID: 8097963
    [Abstract] [Full Text] [Related]

  • 12. Tyrosine phosphorylation at the membrane-microfilament interface: a p185neu-associated signal transduction particle containing Src, Abl and phosphorylated p58, a membrane- and microfilament-associated retroviral gag-like protein.
    Juang SH, Carvajal ME, Whitney M, Liu Y, Carraway CA.
    Oncogene; 1996 Mar 07; 12(5):1033-42. PubMed ID: 8649794
    [Abstract] [Full Text] [Related]

  • 13. Mutation of the human neu protein facilitates down-modulation by monoclonal antibodies.
    van Leeuwen F, van de Vijver MJ, Lomans J, van Deemter L, Jenster G, Akiyama T, Yamamoto T, Nusse R.
    Oncogene; 1990 Apr 07; 5(4):497-503. PubMed ID: 1970152
    [Abstract] [Full Text] [Related]

  • 14. Comparative effect of muramyl dipeptide in vivo and in vitro on the tumoricidal activity of rat peritoneal macrophages.
    Reisser D, Jeannin JF, Lagadec P, Martin F.
    J Biol Response Mod; 1985 Oct 07; 4(5):460-3. PubMed ID: 4078593
    [Abstract] [Full Text] [Related]

  • 15. Activation of an EGFR/neu chimeric receptor: early intracellular signals and cell proliferation responses.
    Pandiella A, Lehvaslaiho H, Magni M, Alitalo K, Meldolesi J.
    Oncogene; 1989 Nov 07; 4(11):1299-305. PubMed ID: 2573029
    [Abstract] [Full Text] [Related]

  • 16. p185neu is phosphorylated on tyrosine in human primary breast tumors which overexpress neu/erbB-2.
    Wildenhain Y, Pawson T, Blackstein ME, Andrulis IL.
    Oncogene; 1990 Jun 07; 5(6):879-83. PubMed ID: 1694290
    [Abstract] [Full Text] [Related]

  • 17. Lipophilic muramyl dipeptide-induced changes in electron microscopic morphology and phagocytic function of murine macrophages.
    Masihi KN, Ozel M, Lange W, Azuma I.
    J Biol Response Mod; 1986 Feb 07; 5(1):20-6. PubMed ID: 3958752
    [Abstract] [Full Text] [Related]

  • 18. Anti-receptor antibodies reverse the phenotype of cells transformed by two interacting proto-oncogene encoded receptor proteins.
    Wada T, Myers JN, Kokai Y, Brown VI, Hamuro J, LeVea CM, Greene MI.
    Oncogene; 1990 Apr 07; 5(4):489-95. PubMed ID: 1970151
    [Abstract] [Full Text] [Related]

  • 19. The role of erbB-2 and its ligands in growth control of malignant breast epithelium.
    Lupu R, Dickson RB, Lippman ME.
    Princess Takamatsu Symp; 1991 Apr 07; 22():49-60. PubMed ID: 1688228
    [Abstract] [Full Text] [Related]

  • 20. Expression, purification, and characterization of Bacneu. A soluble protein tyrosine kinase domain encoded by the neu-oncogene.
    Myers JN, LeVea CM, Smith JE, Kallen RG, Tung L, Greene MI.
    Receptor; 1992 Apr 07; 2(1):1-16. PubMed ID: 1362129
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.